Answer
Pancreatitis has been reported with gilteritinib fumarate; patients with suggestive signs or symptoms should be evaluated and monitored, and treatment should be interrupted and may resume at a reduced dose once symptoms and signs resolve.
Sources for this answer
- Gilteritinib Astellas 40 mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked